StudyRareStudyRare

Neurological Disorders

60 conditions|28 ABGC-listed

Overview

This chapter covers the largest category of genetic disorders: conditions affecting the brain, spinal cord, peripheral nerves, and muscles. Key themes include:

Structural brain anomalies often present prenatally on ultrasound or MRI. Many are associated with syndromes and have specific gene associations (e.g., SHH in holoprosencephaly, ZIC2, SIX3).

Trinucleotide repeat disorders are a core concept. Key principles are anticipation (expansion across generations), parent-of-origin effects, and the difference between CAG (polyglutamine) repeats vs. non-coding repeats.

Neuromuscular disorders require understanding of dystrophin (DMD/BMD), repeat expansions (myotonic dystrophy), and SMN1 copy number (SMA).

Neurocutaneous syndromes (NF1, NF2, TSC) are tumor suppressor disorders with increased cancer risk.

Trinucleotide Repeat Disorders

Nucleotide repeat disorders
Nucleotide repeat disorders

Anticipation: earlier onset and/or more severe phenotype in successive generations, driven by repeat expansion during gametogenesis.

Parent-of-origin: CAG repeats (Huntington, most SCAs) typically expand on paternal transmission. CGG (Fragile X) and CTG (DM1) expand on maternal transmission.

Inheritance: autosomal dominant for most (Huntington, the SCAs, DM1, DM2). Friedreich ataxia is the AR exception. Fragile X (FMR1) and SBMA / Kennedy disease (AR) are X-linked.

Coding vs non-coding: CAG sits in coding regions, producing toxic polyglutamine proteins (gain-of-function). Because they have to fit inside an open reading frame, pathogenic CAG expansions stay relatively short, typically ~36-100 repeats. CGG, CTG, CCTG, and GAA sit in untranslated or intronic regions and act through gene silencing or RNA toxicity; freed from that constraint, these expansions can balloon into the thousands (DM2 CCTG up to ~11,000; FXN GAA into the high hundreds; FMR1 CGG full mutations >200 and often >1,000). The size disparity is itself a teaching point: when you see a "thousands-of-repeats" expansion, the mechanism is almost never polyQ.

Structural brain anomalies

These conditions involve abnormal brain development detectable on prenatal ultrasound or MRI. The key imaging findings (lissencephaly, holoprosencephaly, cobblestone cortex) link to specific genes. Many are associated with facial dysmorphisms; "the face predicts the brain" applies to midline defects like holoprosencephaly.

X-linked neurodevelopmental

These X-linked conditions predominantly affect males, with carrier females often showing milder features. Fragile X is a key trinucleotide repeat disorder with unique inheritance (anticipation through maternal transmission only). Rett syndrome is essentially exclusive to females because it's lethal in males. The characteristic physical and behavioral features help distinguish these conditions clinically.

Other X-linked neurodevelopmental conditions live elsewhere in the library, filed under the organ system their vignette centers on: Lesch-Nyhan syndrome under purine and pyrimidine disorders, oral-facial-digital syndrome type 1 under craniofacial disorders, and Lowe syndrome under genetic kidney disease. Craniofrontonasal syndrome is the inheritance-pattern exception worth flagging here: it's X-linked, but heterozygous females are affected more severely than hemizygous males, the opposite of every other condition on this page.

Autosomal recessive neurodevelopmental

These AR conditions often involve ciliopathy genes, meaning they share overlapping features and genetic heterogeneity. Joubert's "molar tooth sign" on MRI is pathognomonic. Many of these conditions have significant genetic heterogeneity, so the clinical features are more useful than any single gene.

Autosomal dominant neurodevelopmental

These AD conditions are usually de novo, so recurrence risk is low (but consider germline mosaicism). Many involve recognizable facial features or physical findings. CHARGE and Cornelia de Lange have clinical diagnostic criteria built on major and minor features.

Neurodegenerative - Ataxias

Hereditary ataxias cause progressive cerebellar dysfunction with gait instability, limb incoordination, and dysarthria. Friedreich ataxia (FXN, GAA repeat, AR) is the most common hereditary ataxia; it presents before age 25 with progressive gait ataxia, cardiomyopathy, and diabetes. Unlike the dominant SCAs, Friedreich does NOT show anticipation. The spinocerebellar ataxias (SCAs) are AD trinucleotide repeat disorders distinguished by their associated features: SCA1 (pyramidal signs), SCA2 (slow saccades), SCA3/Machado-Joseph (bulging eyes), SCA7 (retinal degeneration).

Neurodegenerative - Movement disorders

Inherited movement disorders that cause abnormal involuntary movements without prominent ataxia or dementia. Dopa-responsive dystonia (Segawa syndrome, GCH1) is the classic example: childhood-onset dystonia with diurnal worsening that responds dramatically to low-dose levodopa. Always trial L-DOPA in early-onset dystonia before assuming a non-treatable cause.

Neurodegenerative - Dementias

Dementia is a clinical symptom of progressive cognitive decline severe enough to interfere with daily functioning. It affects memory, thinking, language, judgment, and behavior (deMEMtia = MEMory loss). Dementia is a symptom, not a diagnosis - it can be caused by many conditions (Alzheimer's, FTD, vascular disease, Lewy body disease, etc.). Alzheimer's disease is the most common cause of dementia.

Also note that dementia represents a decline from a previously healthy baseline, while intellectual disability is present from early development.

FeatureDementiaParkinsonism
What is it?Clinical syndrome of progressive cognitive declineClinical syndrome of movement disorder
Core symptomsMemory loss, language problems, impaired judgment, behavioral changesResting tremor, bradykinesia, rigidity, postural instability
AffectsCognition (thinking, memory)Movement (motor function)
Common causesAlzheimer's, FTD, vascular, Lewy body, HuntingtonParkinson disease, Lewy body, MSA, PSP, drug-induced
Key pointBoth are clinical symptoms, not diagnoses - must find underlying cause

Note: Some conditions cause BOTH (e.g., Lewy body dementia, Huntington disease, some FTD subtypes)

Neuromuscular - Muscular dystrophies

Muscular dystrophies feature progressive muscle weakness and degeneration. DMD and BMD are allelic (same gene, different severity); the reading frame rule predicts phenotype. Look for Gowers sign (using arms to stand from floor) and highly elevated CK. DMD is the most common severe childhood form; BMD has later onset and slower progression.

Neuromuscular - Myotonic dystrophies

Myotonic dystrophies feature myotonia (delayed muscle relaxation) plus multi-system involvement. DM1 is another key trinucleotide repeat disorder with anticipation - unique features include maternal anticipation for congenital form, cataracts, and cardiac conduction defects. The "can't let go of handshake" is classic myotonia. DM2 is milder and lacks severe congenital form.

Peripheral neuropathies

Peripheral neuropathies affect the nerves outside the brain and spinal cord. CMT is the most common inherited neuropathy, with a notable duplication/deletion relationship (CMT1A = PMP22 duplication, HNPP = PMP22 deletion). Look for distal weakness, foot deformities (pes cavus), and "stork legs" appearance.

The peripheral nervous system is divided into somatic (movements what you can feel and control) and autonomic (involuntary actions like your heart rate and sweating) systems. Think of the autonomic nervous system as the 'automatic' nervous system (works without you having to think about it). As you are learning about this class of disorders, think about which branch of the peripheral nervous system is affected in each disorder.

BAFopathies (SWI/SNF complex disorders)

The BAF (mammalian SWI/SNF) chromatin-remodeling complex uses ATP hydrolysis to reposition nucleosomes and regulate transcription. Pathogenic variants in any of its many subunit genes produce overlapping neurodevelopmental phenotypes: intellectual disability, characteristic coarse facial features, and limb/digit hypoplasia (especially the 5th fingers and toes). Coffin-Siris syndrome (most often ARID1B) is the prototype; Nicolaides-Baraitser syndrome (SMARCA2) is the closely related sibling. Almost all cases are de novo. Recognize the BAFopathy gestalt (coarse facies + 5th-digit nail hypoplasia + corpus callosum abnormalities) and order a SWI/SNF gene panel.

Summary Table

DisorderGeneInheritanceCardinal Features
Fragile XFMR1 CGG repeatXLDID, long face, macroorchidism, autism
RettMECP2XLDRegression, hand stereotypies, females
MECP2 duplicationXq28 dupXLRSevere ID, hypotonia → spasticity, recurrent infections (males)
Coffin-LowryRPS6KA3XLDID, coarse facies, tapered fingers, kyphoscoliosis
MenkesATP7AXLRKinky hair, neurodegeneration, low copper/ceruloplasmin
HuntingtonHTT CAG repeatADChorea, psychiatric, dementia, anticipation
SCAsATXN1/2/3/6/7ADCerebellar ataxia, anticipation (paternal CAG)
Friedreich ataxiaFXN GAA repeatARAtaxia, cardiomyopathy, pes cavus
Ataxia w/ OMA (AOA1/2)APTX, SETXARCerebellar ataxia + oculomotor apraxia; elevated AFP (AOA2)
Familial AlzheimerAPP, PSEN1/2ADEarly-onset dementia; APOE ε4 is risk factor
Familial ParkinsonLRRK2, SNCA, PARK2AD/ARParkinsonism, often younger onset
FTDMAPT, GRN, C9orf72ADBehavioral/language onset, ALS-FTD spectrum
ALSSOD1, C9orf72ADUMN + LMN degeneration, fasciculations, dysarthria
SMASMN1 deletionARHypotonia, fasciculations, preserved intellect
SBMA (Kennedy)AR CAG repeatXLRAdult LMN-only, bulbar, gynecomastia, androgen insensitivity
Dopa-responsive dystoniaGCH1ADChildhood dystonia, diurnal variation, levodopa response
DMDDMD (out-of-frame)XLRGowers sign, high CK, no dystrophin
BMDDMD (in-frame)XLRMilder, ambulatory into adulthood, cardiomyopathy
LGMDSarcoglycans, calpain-3, othersAD/ARProximal weakness, elevated CK; some w/ cardiac
FSHDD4Z4 contraction, SMCHD1ADFacial weakness, scapular winging, asymmetric
Emery-DreifussEMD, LMNAXLR/AD/AREarly contractures, conduction defects
OPMDPABPN1 GCN repeatADLate-onset ptosis, dysphagia
α-dystroglycanopathy CMDPOMT1, FKRP, othersARCMD + brain/eye anomalies (severe: Walker-Warburg)
Walker-WarburgPOMT1, othersARCobblestone lissencephaly, CMD, eye anomalies (lethal)
Nemaline myopathyNEB, ACTA1, othersAD/ARHypotonia, bulbar/respiratory weakness, nemaline rods on biopsy
Malignant hyperthermiaRYR1, CACNA1SADVolatile anesthetic-triggered hyperthermia, rigidity
DM1DMPK CTG repeatADMyotonia, cataracts, anticipation (maternal)
DM2CNBP CCTG repeatADProximal weakness, no congenital form, milder than DM1
CMT1APMP22 dupADDistal weakness, pes cavus, demyelinating NCS
HNPPPMP22 delADPressure-induced focal neuropathies, recurrent
Familial dysautonomiaELP1ARAlacrima, autonomic crises, AJ founder
HoloprosencephalySHH, ZIC2, SIX3AD/sporadicMidline brain/face defects; trisomy 13 association
Miller-Diekerdel 17p13.3 (LIS1)SporadicLissencephaly, severe ID, facial dysmorphism
DCX lissencephalyDCXXLDMales: lissencephaly; females: SBH ("double cortex")
Periventricular nodular heterotopiaFLNAXLDBilateral periventricular nodules, epilepsy; male-lethal
L1 syndromeL1CAMXLRX-linked hydrocephalus, adducted thumbs, spasticity, ID
Bardet-BiedlBBS genesAR (ciliopathy)RP, polydactyly, obesity, renal anomalies, ID
JoubertAHI1, CEP290, othersAR (ciliopathy)Molar tooth sign, hypotonia, abnormal breathing
Meckel-GruberMKS1, TMEM67, othersAREncephalocele + polycystic kidneys + polydactyly (lethal)
CHARGECHD7AD (de novo)Coloboma, heart, choanal atresia, growth/dev, GU, ear
Cornelia de LangeNIPBL, others (cohesin)ADGrowth restriction, limb defects, synophrys, thin lips
Coffin-SirisARID1B, SMARCA4, BAF complexADID, 5th-digit nail/phalanx hypoplasia, coarse facies
KabukiKMT2D, KDM6AAD/XLDArched eyebrows, long palpebral fissures, fingertip pads
Rubinstein-TaybiCREBBP, EP300AD (de novo)Broad thumbs/halluces, beaked nose, ID
Mowat-WilsonZEB2AD (de novo)Hirschsprung, severe ID, uplifted earlobes
Pitt-HopkinsTCF4AD (de novo)Severe ID, hyperventilation/apnea, wide mouth
Phelan-McDermid22q13.3 del / SHANK3AD (de novo)Autism, severe speech delay, hypotonia
Pallister-HallGLI3ADHypothalamic hamartoma, central polydactyly, bifid epiglottis
CockayneERCC6, ERCC8ARCachectic growth failure, photosensitivity, neurodegeneration, NO cancer
CADASILNOTCH3ADRecurrent strokes, migraine w/ aura, anterior temporal WMH
Familial CCMKRIT1, CCM2, CCM3ADCavernous malformations, "popcorn" MRI, seizures
Sturge-WeberGNAQSomatic mosaicV1 port-wine stain, leptomeningeal angioma, glaucoma
NF1NF1ADCAL spots, neurofibromas, Lisch nodules
NF2NF2ADBilateral vestibular schwannomas
TSCTSC1/TSC2ADAsh-leaf spots, tubers, rhabdomyomas
Dravet (SCN1A)SCN1AAD (de novo)Prolonged febrile sz, refractory, avoid Na blockers
KCNQ2-relatedKCNQ2ADBenign familial neonatal seizures or encephalopathy
DEPDC5 epilepsyDEPDC5ADFamilial focal epilepsy, focal cortical dysplasia (mTOR)
AHCATP1A3AD (de novo)Alternating hemiplegia, episodes resolve with sleep